Gastrointestinal Conditions News

For the first time since 2001, the Infectious Diseases Society of America has updated its practice guidelines for the diagnosis and management of infectious diarrhea.

The use of beta-lactam or macrolide antibiotics in young children who are genetically at risk for type 1 diabetes or celiac disease before seroconversion was not linked to the future risk of celiac disease autoimmunity or type 1 diabetes, according to a study published in JAMA Pediatrics.

California Governor Edmund G. Brown Jr. declared a state of emergency today to increase the number of adult hepatitis A vaccines needed to contain the state’s ongoing epidemic.

Only cooking pork meat to well-done temperatures — not to rare or medium-level temperatures — in a static oven fully eliminated Salmonella and Listeria pathogens, according to findings published in Risk Analysis.

Environmental exposures in early life, including breastfeeding and NICU admission, appeared to impact the risk for developing eosinophilic esophagitis by interacting with particular gene variants, according to new research.

Pediatric constipation is one of the most frequently treated chronic conditions worldwide, according to a review by Nurko and colleagues in the American Family Physician. Researchers noted that the condition is the catalyst for 3% of all primary care visits, as well as 10% to 25% of all pediatric gastroenterology visits.

Polyethylene glycol or PEG 3350 — commonly known as MiraLAX — has been in the news during the past few years due to the concern for potential side effects in children, most notably undesirable behavioral changes. Although the FDA has not approved long-term use of PEG 3350 in children aged younger than 17 years of age, the laxative is used off-label widely in clinical practice.

Magnetic resonance enterography showed high accuracy for diagnosing active inflammation in children with known or suspected inflammatory bowel disease, according to a meta-analysis published in JAMA Pediatrics.

SAN DIEGO — Louise Ivers, MD, MPH, DTM&H, director of global health at Massachusetts General Hospital in Boston, discusses a roadmap released by the Global Task Force on Cholera Control (GTFCC) on Oct. 4 that aims to reduce 90% of cholera-related deaths by 2030.

The administration of pentavalent rotavirus vaccine, BRV-PV, during infancy was found to be safe, well-tolerated and 55% effective in severe cases of rotavirus gastroenteritis, according to phase 3 results published in Vaccine.